Intraperitoneal chemotherapy for primary gastric cancer
Open Access
- 26 September 2023
- journal article
- research article
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2023 (9)
Abstract
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of intraperitoneal chemotherapy (IPC) in people with primary gastric cancer, with or without peritoneal metastasis.Keywords
This publication has 57 references indexed in Scilit:
- Description of a novel approach for intraperitoneal drug delivery and the related deviceSurgical Endoscopy, 2012
- Pharmacokinetics and Pharmacodynamics of Intraperitoneal Cancer ChemotherapeuticsClinical Pharmacokinetics, 2012
- Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Improves Survival of Patients with Peritoneal Carcinomatosis from Gastric Cancer: Final Results of a Phase III Randomized Clinical TrialAnnals of Surgical Oncology, 2011
- Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 PatientsAnnals of Surgical Oncology, 2010
- Intraperitoneal chemotherapy for gastric carcinomaCochrane Database of Systematic Reviews, 2009
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- Intraperitoneal Hyperthermic Perfusion Combined with Surgery Effective for Gastric Cancer Patients with Peritoneal SeedingAnnals of Surgery, 1988
- Prophylactic therapy for peritoneal recurrence of gastric cancer by continuous hyperthermic peritoneal perfusion with mitomycin CCancer, 1988